New treatments for head and neck cancer using advanced imaging techniques
Transformable Theranostics for imaging-guided interventions in head and neck squamous cell carcinoma
['FUNDING_SBIR_2'] · THERANOSTEC, INC. · NIH-10829794
This study is testing a new treatment that uses tiny particles to help doctors find and treat head and neck cancer more accurately, aiming to make surgeries safer and improve recovery for patients.
Quick facts
| Phase | ['FUNDING_SBIR_2'] |
|---|---|
| Study type | Nih_funding |
| Sex | All |
| Sponsor | THERANOSTEC, INC. (nih funded) |
| Locations | 1 site (CARMICHAEL, UNITED STATES) |
| Trial ID | NIH-10829794 on ClinicalTrials.gov |
What this research studies
This research focuses on developing Transformable Nano-Theranostics (TNTs) to improve the precision of image-guided interventions for patients with head and neck squamous cell carcinoma (HNSCC). The approach aims to enhance the detection and treatment of tumors while minimizing damage to surrounding healthy tissues. By translating these innovative therapies into clinical trials, the research seeks to address the challenges of tumor recurrence and metastasis, which are significant concerns for patients with HNSCC. The goal is to improve surgical outcomes and overall survival rates for affected individuals.
Who could benefit from this research
Good fit: Ideal candidates for this research are patients diagnosed with recurrent or metastatic head and neck squamous cell carcinoma.
Not a fit: Patients with early-stage head and neck cancer or those not diagnosed with squamous cell carcinoma may not benefit from this research.
Why it matters
Potential benefit: If successful, this research could lead to more effective treatments that significantly improve survival rates and quality of life for patients with head and neck cancer.
How similar studies have performed: Other research has shown promise in using theranostic agents for cancer treatment, indicating potential success for this novel approach.
Where this research is happening
CARMICHAEL, UNITED STATES
- THERANOSTEC, INC. — CARMICHAEL, UNITED STATES (ACTIVE)
Researchers
- Principal investigator: LIN, TZU-YIN — THERANOSTEC, INC.
- Study coordinator: LIN, TZU-YIN
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.
Conditions: cancer metastasis